Pharmasin

1 x 1 kg

Granules

Active substance

Tylosin (Tylosin phosphate) : 20.000 IU/g

ATC code

QJ01FA90 Tylosin

QJ01FA Macrolides

QJ01F Macrolides, lincosamides and streptogramins

QJ01 Antibacterials for systemic use

QJ Antiinfectives for systemic use

Species

Pigs.

Indications

Pigs: Treatment and metaphylaxis of clinical signs of porcine proliferative enteritis (porcine intestinal adenomatosis, proliferative hemorrhagic enteropathy, ileitis) associated with Lawsonia intracellularis when the disease has been diagnosed at the group level.

Dose to be administered and administration route

Oral use.

For use in individual pigs on farms where only a small number of pigs are to receive the medicine. Larger groups should be treated with medicated feeding stuff containing the premix.

Individual pigs should receive 5000 IU tylosin per kg bodyweight, corresponding to 250 mg product/kg bodyweight, once a day for 3 weeks. This is achieved by thoroughly mixing the product into the daily ration for each individual pig. The required amount of product should be added to the estimated quantity of daily ration for each pig in a bucket or similar receptacle and thoroughly mixed. The product should only be added to dry non-pelleted feed.

To ensure a correct dosage, body weight should be determined as accurately as possible.

Should there be no clear response to treatment within 3 days the treatment approach should be reconsidered.

Adverse reactions

Pigs:

Undetermined frequency (cannot be estimated from available data)

Diarrhoea, rectal prolapse

Rectal oedema

Pruritus, erythema

Reporting adverse events is important. It allows continuous safety monitoring of a veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to either the marketing authorisation holder or its local representative or the national competent authority via the national reporting system. See package leaflet for respective contact details.